Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

A phase II, Open-Label, Single-Arm Trial of Carboplatin Plus Etoposide with Bevacizumab and Atezolizumab in Patients with Extended-Stage Small-Cell Lung Cancer (CeLEBrATE study): Background, Design and Rationale

Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies